The National Hemophilia Foundation does not endorse or assure the products, programs or services featured in eNotes. Further, it cannot make specific recommendations for such products, programs or services.
Industry News for May 2013 eNotes
Antiviral Oral Combination Treats Certain HCV Patients
Achillion Drug Begins Phase 2 Trial in HCV Patients
Gilead Announces HCV Drug Sofosbuvir Clinical Trial Results
CSL Donates to WFH GAP Program
Industry News for April 2013 eNotes
Baxter Submits FDA Application for Prophylactic FEIBA for Inhibitor Patients
Pfizer Halts Development of HCV Drug
FDA Accepts Biogen’s Application for Longer-Lasting FVIII Product
CSL’s FXIII Product Approved for Expanded Use
Industry News for March 2013 eNotes
Biogen Reports A-LONG and B-LONG Studies Progress
Gilead’s HCV Therapy Trials On Track
Idenix Ceases Development of Two HCV Drugs
Cangene to Acquire IB1001 from Inspiration
Industry News for February 2013 eNotes
CSL Behring Enrolls Pediatric Patient in Hemophilia B Study
Green Cross Initiates Phase III Trial of rFVIII Product
Baxter Announces Inhibitor Study Results, Acquisition of Inspiration’s Assets
Apply Now for Pfizer’s ASPIRE Research Awards Program
Biogen Idec Submits FDA Application for Long-Acting FIX Therapy
Industry News for January 2013 eNotes
Baxter Presents Data on Developmental Recombinant FIX Product
Industry News for December 2012 eNotes
Grifols Publishes Research Award Recipients
Novo Nordisk Announces Results from HERO Study, Launches New Mobile App
Inspiration’s OBI-1 Receives FDA Fast Track Designation
Bayer Reports Progress on Study Recruitment for BAY 86-6150
Industry News for November 2012 eNotes
Novo Nordisk Seeks Regulatory Approval for Recombinant FVIII Drug
Abbott Announces Success in HCV Triple Drug Combo Trial
Industry News for October 2012 eNotes
PBB Reports Progress on New Hemophilia Therapies
Baxter Applies to FDA for New rFIX License
South Carolina Medical Center Receives $400,000 from Aflac
Biogen Reports Positive Results from FIX B-LONG Study
Industry News for September 2012 eNotes
FDA Rescinds Exclusivity for Octapharma’s Wilate®
Inspiration Announces Global Agreement with Ipsen
Setbacks for Hepatitis C Drugs in Clinical Trials
Industry News for August 2012 eNotes
Bayer Enrolls Patients in Longer-acting rFVIII Trial, Announces Kogenate® Trial Results
Novo Nordisk Announces HERO Study Results
Baxter Announces New ADVATE Dosage Strength
FDA Puts Clinical Hold on Inspiration’s Trials of rFIX
Bayer Announces 2012 BHAP Award Recipients
Industry News for July 2012 eNotes
Baxter and Chatham Partner to Develop Hemophilia Treatments
CSL Behring Announces Orphan Drug Designation for rFIX Therapy
Industry News for June 2012 eNotes
Achillion Begins Trial of New HCV Drug ACH-3102, Announces Fast Track Status
NasalCEASE® Gives Back to NHF Research
Industry News for May 2012 eNotes
Inspiration Files for Licensing of rFIX Drug
CSL Doses First Inhibitor Patients in Trial of New rFVII Product
Industry News for April 2012 eNotes
Vertex Announces Interim Results of Telaprevir Studies in Co-Infected Patients
Okairos Begins Next Phase of HCV Vaccine Study
CSL Announces First Patient Screened for New rFVIII Trial
Bayer Stresses Filtration Step for Kogenate® FS Users
REGENX/Chatham to Develop Genetically Based Hemophilia Therapies
Industry News for March 2012 eNotes
CSL Behring Updates Therapies in Development
Pfizer Announces New BeneFIX® Vial Size
Industry News for February 2012 eNotes
CSL Announces Site for Longer-Acting Recombinant FIX Study
AMT’s Hemophilia B Gene Therapy Program Granted Orphan Drug Status
Catalyst Initiates Phase I Trial for rVIIa Product for Inhibitors
Achillion’s HCV Drug Receives Fast Track Designation
Industry News for January 2012 eNotes
Baxter Announces Approval of ADVATE for Prophylaxis and Longer-Acting rFVIII Trial
Industry News for December 2011 eNotes
FDA Approves Pfizer’s BeneFIX® 3,000 IU Dosage
Industry News for November 2011 eNotes
Baxter’s Recombinant VWF Product Starting Phase 3 Clinical Trial
Bayer Standardizes Syringe for Kogenate®FS Vial Sizes
Industry News for September 2011 eNotes
Pfizer Announces Improvements to XYNTHA® and BeneFIX®
Industry News for August 2011 eNotes
Baxter Reports Progress on Hemophilia and Recombinant VWF Treatments
Biogen Idec and Swedish Orphan Biovitrum Report Clinical Progress
CSL Donates Factor to WFH’s GAP Program
Inspiration Presents Data on Recombinant FVIII Product
Bayer HealthCare Announces 2011 BHAP Winners
Industry News for July 2011 eNotes
FTC Approves Grifols-Talecris Merger, Kedrion Acquisition of Koate-DVI
Industry News for June 2011 eNotes
FDA Approves Longer Storage for Bayer’s Kogenate® FS
CSL Behring Receives NORD Corporate Award
Industry News for May 2011 eNotes
Amunix to Collaborate with Biogen Idec on Recombinant Therapies
Novo Nordisk Launches Virtual Surgical Center
Industry News for April 2011 eNotes
MedPro Rx Supports KIDBase Program
Industry News for March 2011 eNotes
Inspiration Biopharmaceutical’s Recombinant FIX Performs Well in Clinical Trial
Grifols’ Alphanate Label Reflects Capacity to Prevent TSE Infection
Novo Unveils Mobile App to Improve Bleeding Disorder Diagnosis
CSL Donates FVIII to WFH Program
Industry News for February 2011 eNotes
CSL Announces LEAD Grant Recipients
Grifols Develops Flash Drive for Hemophilia Patients
Industry News for January 2011 eNotes
Novo Reports Progress on Two Therapies
Biogen Idec and Swedish Orphan Biovitrum Announce Trial of Longer-Acting rFVIII
Baxter Presents New VWD Treatment Data
Industry News for December 2010 eNotes
Inspiration Reports Clinical Study of OBI-1 in Hemophilia A Patients
Octapharma Announces First Trial Recipients of rFVIII from Human Cell Line
Baxter to Acquire Archemix’s Hemophilia Therapy Assets
“Next Generation” of HeliTrax® System Now Available
Industry News for November 2010 eNotes
Octapharma Announces Research Application Deadline and Launch of New Web Site
Industry News for September 2010 eNotes
Sign up for PPTA’s September Health Reform Webinar
Chicago HTC Receives Octapharma Research Award
Baxter’s ADVATE® Maintains Safety, Low Inhibitors Risk in Study
FDA Approves New Syringe for Pfizer’s XYNTHA®
NovoSeven® RT Receives FDA Approval for Larger Vial Size
Industry News for August 2010 eNotes
Biogen Idec and Swedish Orphan Biovitrum Report Progress on Hemophilia Therapies
Pfizer Reports on Hemophilia Studies at WFH Congress
UCF Professor Receives Research Grant from Bayer
PPTA To Host Health Reform Webinar
Industry News for July 2010 eNotes
CSL Behring Announces Latest LEAD Grant Awards
Industry News for June 2010 eNotes
Octapharma’s Wilate Now Available from Distributors
Grifols to Acquire Talecris, Pending Approval
Industry News for May 2010 eNotes
Grifols Announces New Needle-Free Factor Mixing Device
Industry News for April 2010 eNotes
CSL Behring Awards New LEAD Advocacy Grants
Industry News for March 2010 eNotes
Octapharma USA Announces Research Grants Application Deadline
Industry News for February 2010 eNotes
MedPro Rx Now Accepting Scholarship Applications
Ipsen and Inspiration Partner to Produce Recombinant Factor Therapies
Biogen Idec and Swedish Orphan Biovitrum Announce Initial Hemophilia B Study Results
Industry News for January 2010 eNotes
MedPro Rx Now Accepting Scholarship Applications
Bayer Provides Summer Leadership Internship
Industry News for December 2009 eNotes
WFH Receives Largest Donation to Humanitarian Aid Program
Ataluren Trial in Hemophilia Patients with Nonsense Mutations
Baxter Launches Education Advantage Scholarship Program
Industry News for November 2009 eNotes
Biogen Idec and Biovitrum AB Announce Clinical Trials for rFIXFc
Pfizer Acquires Wyeth
Baxter Announces PACT Grant Winners
Industry News for October 2009 eNotes
Octapharma Holds Symposia During ISTH Congress
Bayer Facility Stays in Berkeley, Slated for Improvements
Wyeth Announces Scholarship Recipients
Industry News for September 2009 eNotes
Bayer Announces Self-Infusion Training Program and FDA Approval of Larger Kogenate®FS Vial Size
CSL Behring’s Helixate®FS Receives FDA Approval for Prophylaxis in Children
Industry News for August 2009 eNotes
Flamel and Baxter to Develop Longer-Acting Hemophilia Therapies
CSL Behring Improves Data Management System for Hemophilia A Patients
Bayer Announces 2009 International Awards Recognizing Promising Clinicians, Researchers and Nurses
Industry News for July 2009 eNotes
Wyeth and Catalyst to Develop FVIIa Products
Industry News for April 2009 eNotes
Genavia to Access Origen’s Transgenic Animals to Manufacture Factor VIII
Industry News for March 2009 eNotes
Lentigen and Expression to Collaborate on Hemophilia A Therapies
Inspiration Begins Clinical Trial for Recombinant Factor IX Drug
Industry News for February 2009 eNotes
FDA Approves ATryn, First Drug from Genetically Engineered Animals
Pfizer To Acquire Wyeth
Industry News for January 2009 eNotes
Baxter Announces Recombinant VWD Trial
Avigen Sells Coagulation Drug Rights to Baxter
Industry News for December 2008 eNotes
Bayer Schering to Fund HTC Network in China
FDA Grants Orphan Drug Status to Recombinant FIX Product
Industry News for November 2008 eNotes
FDA Approves Prophylactic Use of Kogenate® FS
ADVATE® Performs Well in New Study on Children
Companies Sign Agreement on Factor VIIa Drug Candidate
Industry News for October 2008 eNotes
Grifols Launches New Drug Tracing System
PPTA Web Site Provides Plasma Therapy Information
Industry News for September 2008 eNotes
CSL Ltd. Acquires Talecris
New Clotting Drug Granted Priority Review by FDA
Industry News for August 2008 eNotes
NHF Chapters Receive CSL Advocacy Grants
Bayer Acquires Maxygen’s Recombinant Factor VII Drug Candidate
AMT and St. Jude Partner to Develop Hemophilia B Gene Therapy
Ipsen Acquires OBI-1 Drug
Industry News for July 2008 eNotes
CSL Behring Awards Researchers
Bayer Honors 2008 Awardees at WFH Congress
First Clinical Trial Completed for Longer-Acting Factor VIIa Drug
Baxter Reports Advances in Preclinical Research
Industry News for June 2008 eNotes
Catalyst Biosciences Developing Factor VIIa Drug for Hemophilia Patients
FDA Approves New Recombinant FVIIa Formulation
New Recombinant Factor IX Drug Reaches Clinical Trial Stage
Industry News for May 2008 eNotes
Bayer Launches Electronic Data Device
Industry News for April 2008 eNotes
Promising New Recombinant Factor IX Drug Receives FDA Approval for Clinical Studies
Wyeth Announces FDA Approval of Recombinant Factor VIII Drug
Drug Candidate for TTP Entering Phase 2 Trial
Industry News for February 2008 eNotes
Baxter Developing New Hemophilia B Therapies
Industry News for January 2008 eNotes
ATryn® Receives Orphan Drug Designation
CSL Behring Reports on Potential for Longer-Lasting Factor VIIa Therapy
Nektar Announces Agreement with Baxter to Develop New Hemophilia A Therapy
Industry News for December 2007 eNotes
Hemophilia B Drug Submitted for IND Status Approval
Industry News for November 2007 eNotes
Pharming Group Receives FDA Orphan Drug Status for Fibrinogen
Apria to Acquire Coram, Inc., for $350 Million
Humate-P® No Longer Requires Refrigeration
Industry News for August 2007 eNotes
EpiVax Receives Grant to Study Modified FVIII Proteins
Wyeth Takes Over Distribution of BeneFIX® in Europe
Baxter Study Shows Benefits of Prophylactic Use of Advate®
New Hemophilia B Drug Candidate Presented at ISTH Congress
Bayer Reports Potential Longer-Acting Recombinant Factor VIII with PEG
Industry News for July 2007 eNotes
Bayer Announces WFH’s 2007 International Nursing Fellowship Award Recipients
New Test Designed to Address Variable Warfarin Dosing
CSL Behring Foundation Provides Grants for Bleeding Disorders Research
Novo Nordisk Starts Clinical Trials of Longer-Acting Factor VIIa Product
Two Pharmaceutical Companies To Market New Recombinant Thrombin Product
Wyeth Announces New Self-Infusion Training Kit
Industry News for May 2007 eNotes
Humate-P® Receives FDA Approval for Additional Use
HepaLife Announces Progress in Developing Artificial Liver Device
Talecris Provides Grant for WFH Program in Developing Countries
Grifols Boosts Plasma Collection Capacity
Industry News for April 2007 eNotes
FDA Approves New Biologic for Clotting Disorder
Industry News for March 2007 eNotes
Grifols To Expand Manufacturing Capacity
California Company and Stanford Researchers To Develop FIX Therapy
Wyeth Announces FDA Approval for BeneFIX® Product Enhancements
Industry News for February 2007 eNotes
CSL Behring Will Continue to Sell Helixate® FS
Alphanate® Receives FDA Approval for Some VWD Patients
Wyeth Enters Into Collaborative Research Agreements
Jerini and Baxter AG Formalize Research Collaboration
Industry News for January 2007 eNotes
Lipoxen and Baxter Agree to Develop Improved Recombinant Factor VIII Products
Biogen Idec to Purchase Syntonix and Its Experimental Hemophilia B Drug
CSL Behring Announces Update on Global Name Change
Archives
2006 Industry News Archive